GSK (GSK)
50.10
+1.97 (4.09%)
Upcoming Events
Latest Headlines
Form 6-K GSK plc For: Sep 14
September 14, 2026 7:25 AM - SEC Filing
Form 6-K GSK plc For: Sep 14
September 14, 2026 7:04 AM - SEC Filing
GSK to close German vaccine plant, 641 jobs at risk
September 11, 2026 1:56 PM - StreetInsider
Form 6-K GSK plc For: Sep 11
September 11, 2026 10:31 AM - SEC Filing
Form 6-K GSK plc For: Sep 10
September 10, 2026 10:32 AM - SEC Filing
Form 424B2 GSK plc
September 10, 2026 8:54 AM - SEC Filing
Form 6-K GSK plc For: Sep 10
September 10, 2026 6:09 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP20 at HSBC
September 10, 2026 3:28 AM - StreetInsider
Form 6-K GSK plc For: Sep 09
September 9, 2026 10:45 AM - SEC Filing
Form 6-K GSK plc For: Sep 09
September 9, 2026 10:31 AM - SEC Filing
GSK raises $6.5B in multi-tranche bond offering via US markets
September 9, 2026 6:22 AM - StreetInsider
Form FWP GSK plc Filed by: GSK plc
September 9, 2026 6:20 AM - SEC Filing
RBC Capital Starts GlaxoSmithKline (GSK:LN) (GSK) at Sector Perform
September 9, 2026 3:37 AM - StreetInsider
Form 424B2 GSK plc
September 8, 2026 9:07 AM - SEC Filing
Form 6-K GSK plc For: Sep 08
September 8, 2026 8:28 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP18 at Barclays
September 8, 2026 5:38 AM - StreetInsider
BofA Securities Reiterates Neutral Rating on GlaxoSmithKline (GSK:LN) (GSK)
September 4, 2026 6:07 AM - StreetInsider
Form 6-K GSK plc For: Sep 01
September 1, 2026 12:26 PM - SEC Filing
Form 6-K GSK plc For: Sep 01
September 1, 2026 7:46 AM - SEC Filing
Form 6-K GSK plc For: Aug 26
August 26, 2026 10:38 AM - SEC Filing
FDA approves ViiV Healthcare's Tivicay PD for newborns with HIV
August 26, 2026 10:14 AM - StreetInsider
U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children
August 26, 2026 10:14 AM - BizWire
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19 at Morgan Stanley
August 25, 2026 4:58 AM - StreetInsider
Form 6-K GSK plc For: Aug 24
August 24, 2026 10:35 AM - SEC Filing
Form 6-K GSK plc For: Aug 24
August 24, 2026 6:57 AM - SEC Filing
Form 6-K GSK plc For: Aug 24
August 24, 2026 6:20 AM - SEC Filing
Form 144 GSK plc Filed by: Martinez Maria E
August 20, 2026 11:19 AM - SEC Filing
Form 6-K GSK plc For: Aug 18
August 18, 2026 10:35 AM - SEC Filing
Form SCHEDULE 13G/A GSK plc Filed by: DODGE & COX
August 13, 2026 4:41 PM - SEC Filing
Form 13F-HR GSK plc For: Jun 30
August 13, 2026 4:34 PM - SEC Filing
Form 6-K GSK plc For: Aug 13
August 13, 2026 11:33 AM - SEC Filing
Form 6-K GSK plc For: Aug 11
August 11, 2026 11:03 AM - SEC Filing
Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
August 6, 2026 4:36 PM - StreetInsider
ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future
August 4, 2026 9:12 AM - BizWire
Form 6-K GSK plc For: Aug 03
August 3, 2026 11:17 AM - SEC Filing
Form 6-K GSK plc For: Jul 30
July 30, 2026 12:26 PM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP20 at Deutsche Bank
July 30, 2026 8:55 AM - StreetInsider
ViiV Healthcare HIV drug Cabenuva outperforms daily oral therapy in teens
July 29, 2026 10:17 AM - StreetInsider
Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026
July 29, 2026 10:15 AM - BizWire
Form 6-K GSK plc For: Jul 28
July 28, 2026 1:10 PM - SEC Filing
Form 6-K GSK plc For: Jul 28
July 28, 2026 1:04 PM - SEC Filing
Form 6-K GSK plc For: Jul 28
July 28, 2026 12:51 PM - SEC Filing
GlaxoSmithKline (GSK) Tops Q2 EPS by 4p
July 28, 2026 7:26 AM - StreetInsider
GSK (GSK) call put ratio 9.5 calls to 1 put with a focus on 3200 contracts of August 53 calls
July 27, 2026 2:47 PM - StreetInsider
ViiV Healthcare's Dovato matches Biktarvy efficacy in HIV trial
July 27, 2026 1:00 PM - StreetInsider
ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
July 27, 2026 1:00 PM - BizWire
Form 6-K GSK plc For: Jul 24
July 24, 2026 10:40 AM - SEC Filing
Form 6-K GSK plc For: Jul 24
July 24, 2026 10:13 AM - SEC Filing
Citi Resumes GlaxoSmithKline (GSK:LN) (GSK) at Neutral
July 24, 2026 4:55 AM - StreetInsider
FDA approves GSK lung cancer drug Jideytro ahead of schedule
July 22, 2026 2:00 PM - StreetInsider
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
July 22, 2026 1:59 PM - PR NewsWire
Form 6-K GSK plc For: Jul 22
July 22, 2026 12:52 PM - SEC Filing
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026
July 21, 2026 4:00 AM - BizWire
Form 6-K GSK plc For: Jul 20
July 20, 2026 10:13 AM - SEC Filing
Form 6-K GSK plc For: Jul 17
July 17, 2026 7:14 AM - SEC Filing
GSK halts camlipixant development for chronic cough after mixed results
July 17, 2026 6:55 AM - StreetInsider
Form 6-K GSK plc For: Jul 17
July 17, 2026 6:50 AM - SEC Filing
Form 6-K GSK plc For: Jul 16
July 16, 2026 10:46 AM - SEC Filing
Form 6-K GSK plc For: Jul 15
July 15, 2026 9:12 AM - SEC Filing
Form 6-K GSK plc For: Jul 14
July 14, 2026 11:20 AM - SEC Filing
Form 6-K GSK plc For: Jul 13
July 13, 2026 11:28 AM - SEC Filing
Form 6-K GSK plc For: Jul 13
July 13, 2026 6:29 AM - SEC Filing
Form 6-K GSK plc For: Jul 10
July 10, 2026 8:13 AM - SEC Filing
Form 6-K GSK plc For: Jul 09
July 9, 2026 11:28 AM - SEC Filing
Form 6-K GSK plc For: Jul 09
July 9, 2026 7:28 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19.50 at Deutsche Bank
July 9, 2026 4:59 AM - StreetInsider
GSK terminates collaboration with Alector after trial failures
July 8, 2026 4:13 PM - StreetInsider
HSBC Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Hold
July 6, 2026 1:32 AM - StreetInsider
Form 6-K GSK plc For: Jul 01
July 1, 2026 10:02 AM - SEC Filing
Increasing unusual put option volume: MDLN GSK KVYO BIRK CPRT CIA APD CTSH DT SWKS
June 30, 2026 6:11 AM - StreetInsider
Form 6-K GSK plc For: Jun 29
June 29, 2026 10:26 AM - SEC Filing
Form 6-K GSK plc For: Jun 29
June 29, 2026 10:21 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19 at Barclays
June 29, 2026 4:15 AM - StreetInsider
Form 6-K GSK plc For: Jun 26
June 26, 2026 10:02 AM - SEC Filing
Form 6-K GSK plc For: Jun 24
June 24, 2026 10:46 AM - SEC Filing
Form 6-K GSK plc For: Jun 24
June 24, 2026 10:40 AM - SEC Filing
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026 8:30 AM - StreetInsider
Form 6-K GSK plc For: Jun 23
June 23, 2026 11:05 AM - SEC Filing
Form 6-K GSK plc For: Jun 22
June 22, 2026 11:01 AM - SEC Filing
FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
June 17, 2026 4:21 PM - StreetInsider
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
June 17, 2026 4:21 PM - BizWire
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
June 17, 2026 12:36 PM - Globe NewsWire
Form 11-K GSK plc For: Dec 31
June 17, 2026 12:21 PM - SEC Filing
Form 11-K GSK plc For: Dec 31
June 17, 2026 12:05 PM - SEC Filing
Form 6-K GSK plc For: Jun 17
June 17, 2026 12:02 PM - SEC Filing
GSK receives FDA approval for oral antibiotic to treat UTIs
June 17, 2026 11:09 AM - StreetInsider
Full Article List
